Researcher profile

Alexandra E. Porter

Alexandra E. Porter contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

An AI-driven framework for the prediction of personalised health response to air pollution

Air pollution is a growing global health threat, exacerbated by climate change and linked to cardiovascular and respiratory diseases. While personal sensing devices enable real-time physiological monitoring, their integration with environmental data for individualised health prediction remains underdeveloped. Here, we present a modular, cloud-based framework that predicts personalised physiological responses to pollution by combining wearable-derived data with real-time environmental exposures. At its core is an Adversarial Autoencoder (AAE), initially trained on high-resolution pollution-health data from the INHALE study and fine-tuned using smartwatch data via transfer learning to capture individual-specific patterns. Consistent with changes in pollution levels commonly observed in the real-world, simulated pollution spikes (+100%) revealed modest but measurable increases in vital signs (e.g., +2.5% heart rate, +3.5% breathing rate). To assess clinical relevance, we analysed U-BIOPRED data and found that individuals with such subclinical vital sign elevations had higher asthma burden scores or elevated Fractional Exhaled Nitric Oxide (FeNO), supporting the physiological validity of these AI-predicted responses. This integrative approach demonstrates the feasibility of anticipatory, personalised health modelling in response to environmental challenges, offering a scalable and secure infrastructure for AI-driven environmental health monitoring.

preprint2020arXiv

Label-Free Chemical Nano-Imaging of Intracellular Drug Binding Sites

Optical microscopy has a diffraction limited resolution of about 250 nm. Fluorescence methods (e.g. PALM, STORM, STED) beat this, but they are still limited to 10 s of nm, and the images are an indirect pointillist representation of only part of the original object. Here we describe a way of combining a sample preparation technique taken from histopathology, with a probe-based nano-imaging technique, (s SNOM) from the world of Solid State Physics. This allows us to image subcellular structures optically, and at a nanoscale resolution that is about 100 x better than normal microscopes. By adding a tuneable laser source, we also demonstrate mid-infrared chemical nano-imaging (MICHNI) in human myeloma cells and we use it to map the binding sites of the anti cancer drug bortezomib to less than 10 zL sized intracellular components. MICHNI is label free and can be used with any biological material and drugs with specific functional chemistry. We believe that its combination of speed, cheapness, simplicity, safety and chemical contrast promises a transformative impact across the life sciences.